Additive glucose-lowering effects of glucagon-like peptide- 1 and metformin type 2 diabetes
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Additive glucose-lowering effects of glucagon-like peptide- 1 and metformin type 2 diabetes. / Zander, M.; Taskiran, M.; Toft-Nielsen, M.B.; Holst, J.J.
I: Diabetes Care, Nr. 24, 2001, s. 720-725.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Zander, M, Taskiran, M, Toft-Nielsen, MB & Holst, JJ 2001, 'Additive glucose-lowering effects of glucagon-like peptide- 1 and metformin type 2 diabetes', Diabetes Care, nr. 24, s. 720-725.
APA
Zander, M., Taskiran, M., Toft-Nielsen, M. B., & Holst, J. J. (2001). Additive glucose-lowering effects of glucagon-like peptide- 1 and metformin type 2 diabetes. Diabetes Care, (24), 720-725.
Vancouver
Zander M, Taskiran M, Toft-Nielsen MB, Holst JJ. Additive glucose-lowering effects of glucagon-like peptide- 1 and metformin type 2 diabetes. Diabetes Care. 2001;(24):720-725.
Author
Bibtex
@article{84a6cf0074c711dbbee902004c4f4f50,
title = "Additive glucose-lowering effects of glucagon-like peptide- 1 and metformin type 2 diabetes",
author = "M. Zander and M. Taskiran and M.B. Toft-Nielsen and J.J. Holst",
year = "2001",
language = "English",
pages = "720--725",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association",
number = "24",
}
RIS
TY - JOUR
T1 - Additive glucose-lowering effects of glucagon-like peptide- 1 and metformin type 2 diabetes
AU - Zander, M.
AU - Taskiran, M.
AU - Toft-Nielsen, M.B.
AU - Holst, J.J.
PY - 2001
Y1 - 2001
M3 - Journal article
SP - 720
EP - 725
JO - Diabetes Care
JF - Diabetes Care
SN - 0149-5992
IS - 24
ER -
ID: 170103